Veeva's Florian Schnappauf speaks to Andy Eeckhout of ADVANZ PHARMA about ensuring launch success. Preparing for a launch is a high-stakes gamble for all biopharma companies, particularly those focused on rare diseases. Andy explains how ADVANZ uses data to prepare for a launch, scale across multiple markets, and help MSLs get up-to-speed quickly for an in-depth scientific discussion with experts.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from What Pharma Needs Next
Architecting the AI-Ready Enterprise
UCB and Takeda: Improving the Customer Experience through Medical-Commercial Collaboration
Turning Content into Memorable Customer Experiences
Preparing for a Faster Trial-to-Treatment Pathway
Get summaries like this every morning.
Free AI-powered recaps of What Pharma Needs Next and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.